Target intelligence / Profile preview

PAX-interacting protein 1 (PAXIP1)

Target
PAXIP1
Molecular classification
Chromatin regulator, Histone modification factor, Epigenetic regulator, DNA damage response factor, Nuclear protein, Other
01

Overview

PAX-interacting protein 1 (PAXIP1) is a nuclear protein characterized by six BRCT domains and encoded by the PAXIP1 gene. It is crucial for the maintenance of genome stability, chromatin condensation, and proper progression through mitosis[1][3]. PAXIP1 acts as a cofactor in histone H3 lysine 4 trimethylation via association with the MLL3/4 methyltransferase complexes and links these chromatin-modifying enzymes to gene promoters through direct or indirect interaction with DNA-bound transcription factors, such as members of the paired box (PAX) family[2][3][4][6]. PAXIP1 is involved in DNA double-strand break repair, functioning in both DNA damage signaling and homologous recombination repair pathways, and is required for effective post-irradiation cell survival[3][4]. In lymphocytes, PAXIP1 specifically regulates RAG-mediated chromatin remodeling, cleavage and repair during V(D)J recombination essential for T cell development and immunoglobulin class switching[2]. Loss of PAXIP1 impacts the transcriptional activation of immune-related genes such as sphingosine-1-phosphate receptor 1 (S1PR1), impinging on mature T cell egress from the thymus[2]. PAXIP1 is also implicated as a disease gene in neurodevelopmental and neurodegenerative disorders, including roles in Alzheimer's disease and rare genetic syndromes[1][3]. No known drugs directly target PAXIP1, and it is not currently considered a direct therapeutic target or biomarker[3].

Other names
PAXIP1PTIPTNRC2PAXIP1LCAGF28CAGF29PACIP1PAX transcription activation domain-interacting protein 1PAX transactivation activation domain-interacting proteinPAX interacting (with transcription-activation domain) protein 1
02

Biological functions

Maintenance of genome stabilityChromatin condensationProgression through mitosisDNA damage responseTranscriptional coactivationRegulation of histone methylation (H3K4me3)Regulation of V(D)J recombinationT cell developmentTranscriptional activation of specific genes
03

Disease associations

CancerNeurodegenerative disease (Alzheimer’s disease)Chromosomal instability disordersIntellectual disability syndromes (e.g. Kleefstra Syndrome, Cornelia De Lange Syndrome)Other
04

Safety considerations

Deficiency or dysfunction may disrupt genome integrity, chromatin modification, and lymphocyte development; no drug-specific toxicities identified

Beyond the preview

Go deeper on PAX-interacting protein 1 (PAXIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAX-interacting protein 1 (PAXIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call